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Abstract
ADP-ribosyltransferases (ADPRTs) form an interesting class of enyzmes with well-established roles as potent
bacterial toxins and metabolic regulators. ADPRTs catalyze the transfer of the ADP-ribose moiety from NAD+ onto
specific substrates including proteins. ADP-ribosylation usually inactivates the function of the target. ADPRTs have
become adapted to function in extra- and intracellular settings. Regulation of ADPRT activity can be mediated by
ligand binding to associated regulatory domains, proteolytic cleavage, disulphide bond reduction, and association
with other proteins. Crystallisation has revealed a conserved core set of elements that define an unusual minimal
scaffold of the catalytic domain with remarkably plastic sequence requirements—only a single glutamic acid residue
critical to catalytic activity is invariant. These inherent properties of ADPRTs suggest that the ADPRT catalytic fold
is an attractive, malleable subject for protein design. © 2001 Elsevier Science B.V. All rights reserved.
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1. ADP-ribosyltransferases catalyze
ADP-ribosylation of targets
ADP-ribosyltransferases (ADPRTs) catalyze
the transfer of the ADP-ribose moiety from -
nicotinamide adenine dinucleotide (NAD+) onto
substrates including proteins, small molecular
weight substances, and water, while releasing the
nicotinamide moiety (Fig. 1) (Aktories, 1991;
Haag and Koch-Nolte, 1997). The ADPRT-
catalysed reaction is also designated ADP-ribosy-
lation. Some ADPRTs are promiscuous with
respect to substrate specificity, e.g. several
arginine-specific ADPRTs including Pseudomonas
aeruginosa exoenyzme S and murine ART2 can
ADP-ribosylate several distinct target proteins as
well as simple guanidino compounds (Koch-Nolte
et al., 1996a,b; Radke et al., 1999). Other AD-
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PRTs show exquisite specificity for a single target.
For example, the only known substrate for the
Clostridium botulinum C2 toxin and Salmonella
typhimurium SpvB is actin, while that for diphthe-
ria toxin and pseudomonas exotoxin A is elonga-
tion factor 2 (Aktories et al., 1986;
Tezcan-Merdol et al., 2000; Wilson and Collier,
1992).
2. ADP-ribosylation of proteins
In case of protein substrates, ADPRT catalysed
protein ADP-ribosylation is akin to protein ki-
nase-catalyzed protein phosphorylation. Like
phosphorylation, ADP-ribosylation is a modifica-
tion, which profoundly affects protein function.
Diphtheria toxin-mediated ADP-ribosylation of
elongation factor 2 blocks protein synthesis while
cholera toxin-mediated ADP-ribosylation of the
alpha subunit of the adenylate cyclase regulating
G-protein leads to chronic activation of adenylate
cyclase (Aktories, 1991). Like phosphorylation,
ADP-ribosylation is targeted towards specific
amino acid residues. Subclasses of ADPRTs spe-
cific for arginine, cysteine, asparagine, glutamic
acid, and diphthamide have been characterised.
Like phosphorylation, ADP-ribosylation is poten-
tially reversible. A distinct family of enzymes,
ADP-ribosyl-protein glycohydrolases, can remove
the ADP-ribose moiety from target proteins
(Moss et al., 1992), similar to the removal of
phosphates from proteins by protein phos-
phatases. In both cases, removal of the chemical
group can restore native protein function. Similar
to the autophosphorylation exhibited by some
protein kinases, some ADPRTs can auto-ADP-ri-
bosylate themselves.
3. ADP-ribosylation of small molecules
A number of ADPRTs have been shown to
ADP-ribosylate small molecules. As mentioned
above, exoenzyme S and ART2 can ADP-ribosy-
late L-arginine in target proteins as well as free
L-arginine and simple guanidino compounds.
Some ADPRTs including PARP and tankyrase
catalyze ADP-ribosylation of ADP-ribose itself,
resulting in the formation of long, branched poly-
mers of ADP-ribose (Oliver et al., 1999; Smith et
al., 1998). Recently, a bacterial ADPRT capable
of ADP-ribosylating and thereby inactivating the
antibiotic rifampin was discovered (Quan et al.,
1999). Moreover, a family of enzymes has been
described which can transfer ADP-ribose from
NAD+ to a phosphate group in RNA (Spinelli et
al., 1999). A number of ADPRTs can also utilise
Fig. 1. Schematic diagram of the reaction catalysed by ADP-ribosyltransferases. ADP-ribosyltransferases catalyze the attack by a
nucleophilic target (R) of the -glycosidic bond between nicotinamide and ribose in  nicotinamide adenine dinucleotide, NAD+ .
This results in transfer of the ADP-ribose unit from NAD onto the target (ADP-ribosylation), while nicotinamide is released. Most
commonly, the nucleophile resides in the side chain of a specific amino acid in a specific protein. ADPRTs specific for arginine,
asparagine, glutamic acid, cysteine, and diphthamide (modified histidine) have been characterised by molecular cloning. Some
ADPRTs can also ADP-ribosylate small molecular weight targets, e.g. the arginine-analogue agmatine or even water. The latter
appears as NAD-glycohydrolase (NADase) activity.
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H2O as acceptor for ADP-ribosylation, resulting in
the glycohydrolysis of NAD+ to nicotinamide and
ADP-ribose.
4. Regulation of ADPRT-activity
In the course of evolution, ADPRT catalytic
domains have become associated with diverse reg-
ulatory domains (Bazan and Koch-Nolte, 1997).
Some ADPRTs exhibit constitutive activity, others
require proteolytic cleavage, reduction of a disul-
phide bond, or association with other proteins for
activation. For example, diphtheria toxin is made
as an inactive multidomain precursor protein
(Wilson and Collier, 1992). The receptor-binding
domain determines host cell specificity and the
translocation domain mediates passage thrflough
the cell membrane. Proteolytic cleavage unleashes
the catalytic domain and reduction of a disulphide
bond activates enzyme activity. The activity of
mammalian nuclear poly(ADP-ribosyl)transferases
PARP1 and PARP2 is regulated by binding of
DNA to a linked regulatory domain (Ame et al.,
1999; Oliver et al., 1999).
5. ADPRTs function in many different cellular
compartments
ADP-ribosyltransferase has become well adapted
to function in different cellular compartments.
Mammalian ART1 and ART2 ADP-ribosylate cell
membrane proteins on the extracellular leaflet of
the plasma membrane, PARP1 and PARP2 ADP-
ribosylate numerous nuclear proteins, and vault
PARP ADP-ribosylates components of large cyto-
plasmic multiprotein complexes (Ame et al., 1999;
Kickhoefer et al., 1999; Liu et al., 1999). Many
secretory bacterial ADPRTs ADP-ribosylate cyto-
plasmic target proteins in animal cells (Aktories,
1991; Wilson and Collier, 1992).
6. Topology of the catalytic core of ADPRTs
The crystal structures of six bacterial toxin
ADPRTs (see Note added in Proof) and of chicken
PARP reveal a common topology of the catalytic
domain (Allured et al., 1985; Bell and Eisenberg,
1996; Choe et al., 1992; Han et al., 1999; Ruf et al.,
1998; Sixma et al., 1991; Stein et al., 1994; Zhang
et al., 1995). A conserved core set of six -strands
defines a minimal scaffold with remarkably plastic
sequence requirements—only a single glutamic
acid residue (E in 5) is invariant (Fig. 2) (Bazan
and Koch-Nolte, 1997; Domenighini and Rap-
puoli, 1996; Koch-Nolte et al., 1996a,b). The im-
portance of this residue for catalytic activity was
demonstrated originally by site directed mutagene-
sis in diphtheria toxin (Carrol and Collier, 1984)
and has hence been confirmed in all other ADPRTs
thus examined (Bazan and Koch-Nolte, 1997; Do-
menighini and Rappuoli, 1996). Two other amino
acid residues stabilise the active site and are also
important for catalytic activity. These are histidine
and tyrosine (H in 1, Y in 2) in diphtheria toxin
(DT), pseudomonas exotoxin A (ETA) and
PARP1, but arginine and serine (R in 1 and S in
2) in pertussis toxin (PT), cholera toxin (CT), E.
coli heat labile enterotoxin (LT), and Bacillus
insecticidal toxin VIP2 (Fig. 2) (Bazan and Koch-
Nolte, 1997; Domenighini and Rappuoli, 1996).
7. Residues governing ADPRT target specificity
The conserved topology of the active site crevice
indicates that modern ADPRTs diverged from a
primordial ADPRT, yielding a family of enzymes
with a conserved NAD-binding fold but diverse
target specificities for ADP-ribosylation (Bazan
and Koch-Nolte, 1997; Domenighini and Rap-
puoli, 1996). The residues governing target-specifi-
city have not yet been defined for any of the known
ARTs. The exposed, nonconserved loops, which
cradle the scissile glycosidic bond between ADP-ri-
bose and nicotinamide lie in a position that faces
the incoming target. These loops are highlighted in
yellow, orange, and blue in the 3D structure of VIP2
in Fig. 3. Strikingly, all known arginine-specific
ADPRTs contain a glutamic acid residue at the end
of the loop preceeding 5 (two residues upstream
of the catalytic glutamic acid) (Fig. 2B, Fig. 3).
Mutation of this residue to glutamine has been
shown to convert arginine-specific ADPRT activity
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Fig. 2. Topology cartoon (a) and structure based alignment (b) of the ADPRT catalytic core. Only the structurally conserved
residues are shown. Presumptive active site residues are marked by circles in (a) and by asterisks in (b). The arrow in (a) points to
the proposed loop influencing target specificity. Numbers in (b) indicate amino acid residues from the N-and C-terminal ends of the
proteins and within connecting loops. Names of ADPRTs with known 3D structures are in boldface and their respective  sheet
residues are underlined. Sequences were compiled from database accession numbers: P04977: pertussis toxin (PT); P43530: E. coli
heat labile enterotoxin (LT); D30052: cholera toxin (CT); 1QS2: Bacillus cereus insecticidal toxin (VIP2); X87612: mouse
ecto-ADP-ribosyltransferase (ART2); X00703: diphtheria toxin (DT); P11439: Pseudomonas aeruginosa exotoxin A (ETA); P26446:
chicken poly-ADP-ribose-polymerase (PARP); AF082556: human tankyrase (Tankyr); and AF158255: human vault-PARP
(vPARP).
into NAD-glycohydrolase activity in case of
Clostridium botulinum C2 toxin, Clostridium per-
fringens iota toxin, Pseudomonas exoenyzme S,
and rat ART2 (Barth et al., 1998; Hara et al.,
1996; Karsten et al., 1997; Nagahama et al.,
2000; Radke et al., 1999). PARP contains a large
insertion relative to other ADPRTs preceding 5
and this region has been implicated in binding
the ADP-ribose polymer target (Ruf et al., 1998).
8. Designer ADPRTs
With the three-dimensional structures of kn-
own ADPRTs as a guide, it should be possible
to imitate nature and to alter the target specific-
ity of ADPRTs by mutagenesis. Transforming
existing ADPRTs into one another by site di-
rected mutagenesis and grafting of specificity
loops should be relatively straight forward with
more closely related family members, but poses a
greater challenge for more distant relatives. The
fruit of such endeavours will be a better under-
standing of the structure/function relationship of
ADPRT target specificity. With insight into the
molecular basis of ADPRT target specificity it
may be even possible one day to redirect AD-
PRTs from known to novel targets. Examples
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Fig. 3. Polypeptide backbone (a) and space-fill model (b) of VIP2, an actin-specific ADPRT from Bacillus cereus (Han et al., 1999).
(a) The six beta sheets forming the active site crevice are highlighted in yellow and are labelled as in Fig. 2. The active-site residues
arginine R349, serine S386, and glutamic acid E428 are depicted in red and correspond to the residues marked by asterisks in Fig.
2. The only side chain shown is that of E428. The substrate NAD is depicted in cyan as a stick-model, the arrow points to the scissile
glycosidic bond. (b) Space-fill model of VIP2 is depicted from the same angle as in (a). The active site residues R349, S386 and E428
are in red. The three loops that cradle the scissile glycosidic bond in NAD are highlighted in yellow, orange, and blue. The glutamic
acid residue E426 in the loop preceding 5 which is characteristic of arginine-specific ADPRTs is depicted in green. The figure was
compiled with the Rasmac program using the co-ordinates for Bacillus cereus insecticidal toxin VIP2 (PDB accession number 1QS2).
for practical applications that we envision include
redirecting an ADPRT from fibroblast growth
factor or tuftsin (Jones and Baird, 1997;
Terashima et al., 1997) to other biologically im-
portant signalling peptides; from rifampin (Quan
et al., 1999) to another antibiotic, or from one
nucleotide-binding protein (EF2, actin, G-alpha,
rho, ras) to another key metabolic regulator.
Known ADPRTs have already proven their mani-
fold usefulness as experimental tools in cell biol-
ogy, e.g. to inhibit protein synthesis (ETA, DT),
cytoskeletal functions (C2, C3), signal transduc-
tion (CT, PT), T-cell activation (ART1, ART2)
(Aktories, 1991; Haag and Koch-Nolte, 1997;
Koch-Nolte et al., 1996a,b; Liu et al., 1999;
Wilson and Collier, 1992). It is not hard to imag-
ine that novel designer ADPRTs would be useful
in these and other settings. The properties of
natural ADPRTs— their plasticity in amino acid
sequence requirements, their diverse target specifi-
cities, and their propensity to function in different
environments-suggest that the ADPRT fold repre-
sents an attractive, malleable, and well suited
subject for protein design.
9. Note added in proof
In their recent paper (Han et al., 2001) describ-
ing the 3D structure of the C3 exonenzyme from
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Clostridium botulinum, Tainer and coworkers also
point out the importance of the bipartite loop
connecting 4 and 5 for substrate recognition
specificity (i.e. the loop marked by the arrow in
Fig. 2 and highlighted in blue in Fig. 3.
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